Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy

被引：2
|
作者：
Cooper, Lauren B. [1 ,2 ]
Hernandez, Adrian F. [2 ]
机构：
[1] Inova Heart & Vasc Inst, Falls Church, VA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷 / 08期
关键词：
HEART-FAILURE; HYPERKALEMIA; SPIRONOLACTONE; MORTALITY; ASSOCIATION;
D O I：
10.1002/ejhf.1221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1227 / 1229
页数：3
相关论文
共 50 条
  • [21] The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
    Heinig, Roland
    Eissing, Thomas
    CLINICAL PHARMACOKINETICS, 2023, 62 (12) : 1673 - 1693
  • [22] Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
    Kallistratos, Manolis S.
    Pittaras, Andreas
    Theodoulidis, Iakovos
    Grassos, Charris
    Poulimenos, Leonidas E.
    Manolis, Athanasios J.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (46) : 5537 - 5541
  • [23] Mineralocorticoid receptor antagonist therapy improves vascular function in patients with coronary artery disease
    Cybularz, M.
    Langbein, H.
    Zatschler, B.
    Brunssen, C.
    Deussen, A.
    Matschke, K.
    Morawietz, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 745 - 745
  • [24] Outcome of Adrenal Vein Sampling Performed During Concurrent Mineralocorticoid Receptor Antagonist Therapy
    Haase, Matthias
    Riester, Anna
    Kroepil, Patric
    Hahner, Stefanie
    Degenhart, Christoph
    Willenberg, Holger S.
    Reincke, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12): : 4397 - 4402
  • [25] Mineralocorticoid Receptor Antagonist Therapy Improves Vascular Function in Patients With Coronary Artery Disease
    Cybularz, Maria
    Langbein, Heike
    Zatschler, Birgit
    Brunssen, Coy
    Deussen, Andreas
    Matschke, Klaus
    Morawietz, Henning
    CIRCULATION, 2017, 136
  • [26] Donor Disease Transmission: Minimizing the Risks and Maximizing the Benefits
    Monaco, Anthony P.
    Morris, Peter J.
    TRANSPLANTATION, 2012, 93 (05) : S1 - S3
  • [27] Exercise in diabetes management - Maximizing benefits, controlling risks
    White, RD
    PHYSICIAN AND SPORTSMEDICINE, 1999, 27 (04): : 63 - +
  • [28] Maximizing Benefits and Minimizing Risks in the Primary Prevention of Schizophrenia
    DeVylder, Jordan
    SOCIAL WORK, 2014, 59 (04) : 363 - 365
  • [29] A selective antagonist of mineralocorticoid receptor eplerenone in cardiology practice
    Gegenava, B. B.
    Drapkina, O. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 177 - 181
  • [30] Usefulness of mineralocorticoid receptor antagonist for the treatment of resistant hypertension
    Kikkawa, Kohei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 11P - 11P
12345